Researchers are excited about the medication , a novel dual agonist showing significant results in early trials for weight reduction . It works by impacting both systems: GLP-1 and GIP, these, when activated , support regulate hunger and improve metabolism . Initial observations demonstrate noteworthy body loss and likely advantages for individuals